Lemonn Mobile Sticky Banner

Kwick Forensic Solutions IPO Lists at 66.67% Premium on BSE SME

Prefer us on Google — Button Prefer us on Google
Kwick Forensic Solutions IPO Lists at 66.67% Premium on BSE SME

Kwick Forensic Solutions made a strong stock market debut on September 3, 2026, with its shares listing at ₹150 on the BSE SME platform.

The listing price represented a 66.67% premium over the IPO issue price of ₹90 per share, delivering a sizable listing gain for investors who received shares in the public offer.

Soon after listing, the stock rose another 5% to ₹157.50, reaching its upper circuit, according to Business Standard.

The strong debut followed heavy demand for the ₹50.77 crore SME public issue.

At What Price Did Kwick Forensic Solutions List?

Kwick Forensic Solutions listed at ₹150 per share.

Its final IPO issue price was ₹90.

That means an investor’s notional gain at the listing price was ₹60 per share.

The percentage gain can be calculated as:

₹60 gain ÷ ₹90 issue price × 100 = 66.67%

That is why the company’s market debut was described as a 66.67% premium listing.

The stock later moved to ₹157.50, which was 75% higher than the issue price.

It is important to distinguish between the official listing price and the price at which the stock traded after listing.

Kwick Forensic Solutions IPO Details

IPO detailInformation
Issue size₹50.77 crore
Price band₹85 to ₹90
Final issue price₹90
Listing price₹150
Listing premium66.67%
Lot size1,600 shares
Listing exchangeBSE SME
Listing dateSeptember 3, 2026

The IPO opened for subscription on August 27 and closed on August 31.

The shares were allotted on September 1, followed by credit to demat accounts and refunds on September 2.

How Much Was the Kwick Forensic IPO Worth?

The public offer had an issue size of approximately ₹50.77 crore at the upper end of the price band.

It consisted of a fresh issue and an offer for sale.

Business Standard reported that the offer included 45,61,600 fresh shares and an offer for sale of 10,80,000 shares by selling shareholders.

The fresh issue was worth up to roughly ₹41.05 crore.

The offer-for-sale component was worth up to approximately ₹9.72 crore.

Money raised through a fresh issue goes to the company, subject to issue expenses.

Money from an offer for sale goes to the selling shareholders rather than the company.

What Will Kwick Forensic Use the IPO Money For?

According to Business Standard, Kwick Forensic intends to use proceeds from the fresh issue primarily to fund working-capital requirements and for general corporate purposes.

Working capital is important because businesses need cash to finance day-to-day operations before receiving payment from customers.

For a company supplying specialised technology or equipment, working capital can be used for inventory, supplier payments, project execution and other operating requirements.

Investors should monitor how effectively the company uses the new capital after listing.

How Strong Was Kwick Forensic IPO Subscription?

Demand for the issue was extremely high.

Different market data platforms showed some variation in final subscription calculations, but all indicated heavy oversubscription.

Moneycontrol’s IPO data showed total subscription of around 272.5 times.

Its figures included:

  • Qualified Institutional Buyers: 227.85 times
  • Retail investors: 318.52 times
  • Non-institutional investors: 237.01 times
  • Overall: 272.5 times

Some reports using a different calculation showed overall demand closer to 289 times.

The key takeaway is the same: investor demand substantially exceeded the number of shares available.

Why Did the IPO Receive Such Strong Demand?

There is rarely a single reason behind heavy IPO subscription.

Demand may have reflected a combination of:

  • Interest in the company’s specialised forensic-technology business
  • Expectations of strong listing gains
  • Limited supply of shares
  • SME IPO sentiment
  • Grey-market expectations
  • Retail investor participation

Before the listing, the IPO’s grey market premium had indicated expectations of a strong debut.

However, the grey market is unofficial and unregulated.

Its quoted premium should never be treated as a guaranteed listing price.

What Does Kwick Forensic Solutions Do?

Kwick Forensic Solutions provides products, technologies and services used in forensic investigations.

Its business includes areas such as:

  • Forensic science
  • Fingerprint analysis
  • Cyber forensics
  • Digital forensics
  • Social-media analytics
  • Big-data analytics
  • Evidence management
  • Crime-scene investigation equipment

The company works with government and private-sector customers.

Its customer base includes police departments, forensic laboratories, fingerprint bureaus and training institutions.

Kwick Forensic also provides equipment such as mobile crime-scene investigation vehicles, digital-forensics systems and other forensic tools.

Why Is Forensic Technology a Specialised Business?

Modern investigations increasingly rely on scientific evidence.

Digital devices, surveillance systems, smartphones and online activity have expanded the amount of electronic evidence available to investigators.

At the same time, traditional forensic disciplines such as fingerprints, DNA analysis and physical evidence remain important.

This creates demand for specialised equipment, software and services.

However, the market can also depend heavily on government budgets, procurement cycles and institutional spending.

Investors evaluating Kwick Forensic should therefore consider both growth opportunities and the timing of customer orders.

How Did the Company Perform Financially Before the IPO?

Business Standard reported that Kwick Forensic recorded revenue from operations of ₹105.71 crore for the 12-month period ended March 31, 2026.

Net profit for the period stood at approximately ₹13.50 crore.

These numbers provide a starting point for evaluating the business after listing.

Future performance will depend on whether the company can expand sales while maintaining profitability.

Investors should also examine operating cash flow, receivables and working-capital requirements rather than looking only at revenue and net profit.

What Is a BSE SME Listing?

BSE SME is a platform designed for smaller companies seeking access to public capital markets.

SME IPOs can offer exposure to companies at an earlier stage of growth than many main-board listings.

However, they also carry distinct risks.

Trading liquidity can be lower.

Lot sizes can be larger.

Individual stocks may experience sharp price movements because fewer shares are available for trading.

That is why a strong listing gain should not automatically be interpreted as evidence that a stock is low risk.

Does a 66.67% Listing Gain Guarantee More Returns?

No.

Listing gain and long-term investment performance are different things.

An IPO can list at a large premium and still decline later.

Likewise, an IPO that has a weak debut can potentially perform better over a longer period if the business improves.

After listing, the stock’s performance will increasingly depend on:

  • Revenue growth
  • Profit margins
  • Order execution
  • Customer concentration
  • Cash flow
  • Working-capital management
  • Valuation
  • Corporate governance
  • Overall SME market sentiment

Investors should therefore avoid making decisions solely because the stock delivered a large first-day gain.

What Are the Risks of Investing in SME Stocks?

SME stocks can be considerably more volatile than large-cap equities.

Lower liquidity

There may be fewer buyers and sellers.

That can make it difficult to exit a position quickly at the desired price.

Large lot sizes

SME-market trading often involves mandatory lot sizes, increasing the amount of capital required.

Price circuits

Sharp moves can cause shares to hit upper or lower circuit limits.

Investors may sometimes be unable to buy or sell immediately.

Business concentration

Smaller companies may depend heavily on a limited number of clients, sectors or contracts.

Limited public history

Newly listed companies have shorter track records in the public markets.

Investors may have less information about how management behaves through different market conditions.

What Should Investors Watch After Kwick Forensic’s Listing?

The next set of financial results will be important.

Investors should track whether the company can deploy IPO proceeds effectively and maintain its growth rate.

Useful indicators include:

  • Revenue growth
  • Net profit
  • Operating margins
  • Receivable days
  • Cash flow
  • Order pipeline
  • Government contracts
  • Working-capital utilisation
  • Promoter shareholding

Valuation is equally important.

A good company can still become a poor investment if its stock price assumes unrealistic future growth.

FAQs

At what price did Kwick Forensic Solutions list?

Kwick Forensic Solutions listed at ₹150 per share on the BSE SME platform.

What was the Kwick Forensic IPO issue price?

The final issue price was ₹90 per share.

What was the Kwick Forensic IPO listing gain?

The listing gain was 66.67%, based on a ₹150 listing price compared with the ₹90 issue price.

What was the size of the IPO?

The public issue was worth approximately ₹50.77 crore at the upper end of the price band.

How much was the IPO subscribed?

Final data varied slightly between market platforms, but demand was more than 250 times the shares available. Moneycontrol reported overall subscription of around 272.5 times.

Where is Kwick Forensic Solutions listed?

The shares are listed on the BSE SME platform.

Is a strong IPO listing enough reason to buy the shares?

No. Investors should assess the company’s valuation, financial performance, cash flow, business risks and liquidity before making an investment decision.

Key Takeaways

  • Kwick Forensic Solutions listed at ₹150 on BSE SME.
  • The IPO issue price was ₹90.
  • The official listing premium was 66.67%.
  • The stock subsequently traded as high as ₹157.50.
  • The IPO size was about ₹50.77 crore.
  • Investor subscription was extremely strong.
  • The company operates in specialised forensic and digital-investigation technologies.
  • Strong listing gains do not guarantee long-term returns.

Disclaimer

The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.

Sleek Sticky Registration Footer